Earnings Feed
Start Free
Home/Filings/4/0000914190-21-000358
4//SEC Filing

Furlow Brenda S. 4

Accession 0000914190-21-000358

CIK 0000842023other
View on SEC.govCompany Profile

Filed

Sep 6, 8:00 PM ET

Accepted

Sep 7, 4:58 PM ET

Size

30.3 KB

Accession

0000914190-21-000358

Insider Transaction Report

Form 4
Period: 2021-09-02
BIO-TECHNE CorpTECH
Furlow Brenda S.
SVP - General Counsel
Transactions
  • Sale

    Common Stock

    2021-09-02$510.82/sh−1,576$805,054→ 7,620 total
  • Exercise/Conversion

    Common Stock

    2021-09-02$125.05/sh+6,871$859,219→ 14,491 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2021-09-02−6,871→ 9,503 total
    Exercise: $125.05Exp: 2024-08-09→ Common Stock (6,871 underlying)
  • Sale

    Common Stock

    2021-09-02$509.67/sh−5,295$2,698,711→ 9,196 total
Holdings

  • Stock Options (Right to Buy)

    Exercise: $108.49Exp: 2022-08-07→ Common Stock (921 underlying)
    921

  • Stock Options (Right to Buy)

    Exercise: $177.32Exp: 2025-08-08→ Common Stock (7,339 underlying)
    7,339

  • Stock Options (Right to Buy)

    Exercise: $177.32Exp: 2025-08-08→ Common Stock (9,786 underlying)
    9,786

  • Restricted Stock Units

    → Common Stock (1,969 underlying)
    1,969

  • Stock Options (Right to Buy)

    Exercise: $190.41Exp: 2026-08-07→ Common Stock (9,968 underlying)
    9,968

  • Stock Options (Right to Buy)

    Exercise: $190.41Exp: 2026-08-07→ Common Stock (13,290 underlying)
    13,290

  • Stock Options (Right to Buy)

    Exercise: $267.87Exp: 2027-08-05→ Common Stock (7,492 underlying)
    7,492

  • Stock Options (Right to Buy)

    Exercise: $267.87Exp: 2027-08-05→ Common Stock (9,990 underlying)
    9,990

  • Stock Options (Right to Buy)

    Exercise: $267.87Exp: 2027-08-05→ Common Stock (8,325 underlying)
    8,325

  • Stock Options (Right to Buy)

    Exercise: $372.44From: 2022-08-31Exp: 2028-03-01→ Common Stock (10,997 underlying)
    10,997

  • Stock Options (Right to Buy)

    Exercise: $481.82Exp: 2028-08-06→ Common Stock (4,560 underlying)
    4,560

  • Stock Options (Right to Buy)

    Exercise: $481.82Exp: 2028-08-06→ Common Stock (6,080 underlying)
    6,080

  • Restricted Stock Units

    → Common Stock (1,679 underlying)
    1,679

  • Stock Options (Right to Buy)

    Exercise: $267.87Exp: 2027-08-05→ Common Stock (8,325 underlying)
    8,325

  • Restricted Stock Units

    → Common Stock (1,167 underlying)
    1,167
Footnotes (13)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $509.23 to $510.07, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F10]Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
  • [F11]Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
  • [F12]Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F13]Options to purchase 1,520 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.245 to $511.16, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  • [F4]Fully exercisable.
  • [F5]Options to purchase 2,447 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 2,446 shares vest on each of 8/8/2021 and 8/8/2022.
  • [F6]Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F7]Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023.
  • [F8]Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F9]Options to purchase 2,497 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 2,498 shares vest on each of 8/5/2023 and 8/5/2024.

Documents

1 file

Issuer

BIO-TECHNE Corp

CIK 0000842023

→
Entity typeother

Related Parties

1
  • filerCIK 0001443851

Filing Metadata

Form type
4
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 4:58 PM ET
Size
30.3 KB
View on SEC.gov